In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Editorial Advisory Board
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Guidelines for Contributors
Report Store
UsernamePublicRestriction
Tags:
Medical Device Business Strategies Platform Technologies

Jomed Stakes Out the US

Executive Summary

By all accounts, the one piece missing from the puzzle for Jomed NV, the small European supplier making waves in the highly competitive field of interventional cardiology, has been a US presence. Thus, most industry observers saw the value in Jomed's merger with Endosonics as providing it with a US sales and marketing infrastructure.
Table

View full table

Advertisement

Related Content

In Vivo
The Sorin Group: Europe's Last, Best Hope in Cardiovascular Devices
In Vivo
Millimed models Jomed in interventional neurology
In Vivo
Volcano Steps Up in Vulnerable Plaque By Buying Jomed's IVUS Business
In Vivo
Abbott Moves One Way in Cardiovascular Devices, Another in Orthopedics, To Get To the Same Place
In Vivo
Jomed's Global Positioning
In Vivo
Jomed Goes Public, At Last
In Vivo
Jomed's Rising Star

Topics

Related Companies

Advertisement
Tags:
Medical Device Business Strategies Platform Technologies
UsernamePublicRestriction

Register

IV001490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By